Opko Health Inc. buy melinda
Start price
27.11.17
/
50%
€4.20
Target price
28.05.18
€6.00
Performance (%)
-23.50%
End price
28.05.18
€3.21
Summary
This prediction ended on 28.05.18 with a price of €3.21. The prediction for Opko Health Inc. disappointed with a performance of -23.50%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Opko Health Inc. | - | - | -9.482% | -66.701% |
iShares Core DAX® | -0.870% | -1.700% | 10.560% | 13.129% |
iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% | 39.856% |
iShares Nikkei 225® | -6.138% | -7.732% | 16.215% | 0.044% |
iShares S&P 500 | -3.141% | -2.011% | 24.534% | 39.859% |
Comments by melinda for this prediction
In the thread Opko Health Inc. diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 Ergebnisse Veröffentlichung
OPKO Health, Inc.
OPKO Health registriert seinen ersten Patienten in der Phase 2B von OPK88004 gutartiger Prostatahypertrophie zu behandeln
(Laufzeit überschritten)